Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Novasys Medical
AddedFeb 15, 2024
UpdatedJun 18, 2026
Novasys Medical

Novasys Medical

Acquired

Novasys Medical, Inc. designs non-surgical systems and therapies for female stress urinary incontinence.

HQ
Newark, CA, US
Founded
1998
Overview
Compare
Fundraising
Employees
Website

Novasys Medical, Inc. offers therapies and medical devices.

The Company designs and develops non-surgical systems to treat female stress urinary incontinence.

Novasys Medical - Similar Companies

SRS Medical Systems logo

SRS Medical Systems

Femasys logo

Femasys

femasys.com

Nexgen Medical Systems logo

Nexgen Medical Systems

Neuspera Medical logo

Neuspera Medical

neuspera.com

Channel Medsystems logo

Channel Medsystems

UroCure logo

UroCure

urocure.com

Novogiene logo

Novogiene

Intact Medical logo

Intact Medical

Solace Therapeutics logo

Solace Therapeutics

Nexeon Medsystems logo

Nexeon Medsystems

nexeonmed.com

Percutaneous Systems logo

Percutaneous Systems

Noctrix Health logo

Noctrix Health

noctrixhealth.com

Sinopsys Surgical logo

Sinopsys Surgical

Sensys Medical logo

Sensys Medical

Relievant Medsystems logo

Relievant Medsystems

relievant.com

Novasys Medical - Quick Facts

Who are Novasys Medical's competitors?

Companies similar to Novasys Medical include SRS Medical Systems, Femasys, Nexgen Medical Systems and Neuspera Medical.

When was Novasys Medical founded?

Novasys Medical was founded in 1998.

Where is Novasys Medical's headquarters located?

Novasys Medical's headquarters is located in Newark, CA, US.

When was Novasys Medical's last funding round?

Novasys Medical's most recent funding round was for $3.9M (USD) in August 2012.

How much has Novasys Medical raised to-date?

As of Aug 15, 2012, Novasys Medical has raised a total of $144.9M (USD).

Novasys Medical - Classification

Industry
  • Hardware
Ownership
  • Private
Technology
  • HealthTech
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Medical Devices
Tags
  • Healthcare
  • Medical
  • SaaS
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
SIC
  • 5000Wholesale Trade-durable Goods
  • 5040Professional And Commercial Equipment And Supplies
  • 5047Medical, Dental, And Hospital Equipment And Supplies
Show 7 more industry codes
NAICS
  • 330000Manufacturing
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 3900Miscellaneous Manufacturing Industries
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified